Mechanism-based risk assessment of peroxisome proliferating rodent hepatocarcinogens.
Williams
G M
GM
American Health Foundation, Valhalla, New York 10595, USA.
Perrone
C
C
D000818:Animals; D002273:Carcinogens; D002455:Cell Division / Q000187:drug effects; D002994:Clofibrate; D004249:DNA Damage / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D006801:Humans; D000960:Hypolipidemic Agents / Q000009:adverse effects*; D008113:Liver Neoplasms / Q000139:chemically induced*; D008114:Liver Neoplasms, Experimental / Q000139:chemically induced*; D008830:Microbodies / Q000187:drug effects*; D010084:Oxidation-Reduction; D011323:Primates / Q000502:physiology; D012307:Risk Factors; D015262:Xenobiotics / Q000494:pharmacology
D002273:Carcinogens; D000960:Hypolipidemic Agents; D015262:Xenobiotics; D002994:Clofibrate